Introducing the Lafora Clinical Network Registry

Chelsea’s Hope is proud to announce the launch of the Clinical Network Registry, a centralized resource connecting patients and families to trusted providers dedicated to Lafora disease care.

Centers of Excellence Clinical Network Chelsea's Hope Lafora Children Research Fund

We are excited to announce the launch of the Chelsea’s Hope Clinical Network Registry, a new initiative as part of our Centers of Excellence project, dedicated to connecting patients and families with trusted providers who have experience or interest in treating Lafora disease.

The goal of this registry is to identify clinicians who are committed to advancing the diagnosis, treatment, and holistic management of Lafora disease through coordinated care, patient advocacy, and collaborative expertise. The Lafora Clinical Network will serve as a trusted, centralized resource connecting patients and families to providers with experience or dedicated interest in Lafora disease, ensuring access to knowledgeable, high-quality care.

We invite clinicians to join our network by completing the Clinician Application, where you can share your experience, areas of expertise, and how you would like to connect with patients and families. We also welcome referrals from patients, families, and fellow clinicians through our Referral Form, helping us identify providers who deserve a place in this growing network.

As we build this registry together, we hope to invite the community to help review and shape our standards of care, ensuring this network reflects the needs and experiences of those it supports.

Questions?

Whether you are a clinician ready to join or a family who knows a provider who should be part of this network, we would love to hear from you. Reach out to us at info@chelseashope.org. Thank you for your support of Chelsea’s Hope and your commitment to advancing care for Lafora patients.

Meet our 2026 Summer Interns!

We are thrilled to welcome 16 new interns this summer, supporting the mission through fundraising, creating resources, new webpages, and supporting research and clinical activities.

With backgrounds from pre-med tracks at their schools to studying public health, they are bringing us valuable assistance to drive many projects forward. Keep reading to meet the new team members!

Clinical Support Interns

Amrita PannuAmrita Pannu graduated from the University of California, Berkeley, with a BA in Immunology and a minor in Health and Wellness in May of 2024. She is deeply passionate about community work and is excited to raise awareness for Lafora patients and their families with her work on the Caregiver Support Survey. In addition, she is excited to use her experience in patient advocacy to educate families about Lafora’s ICD-10 code and its significance for not only patients in the healthcare system, but also as a path towards a cure.

Arianna RuizArianna Ruiz is a student at the University of Maryland, College Park, majoring in Public Health Science on the pre-medicine track. Originally from Glen Burnie, Maryland, she is passionate about improving healthcare access and advancing health equity, particularly for individuals living with rare diseases. Her interest in rare disease advocacy and research stems from her own experience living with Type 1 diabetes, which has given her firsthand insight into the challenges patients face when navigating complex healthcare systems. Through her internship with Chelsea’s Hope, Arianna is excited to contribute to efforts that expand research collaboration, strengthen connections between clinicians and families, and make care and resources for individuals affected by Lafora disease more accessible and equitable. She hopes to pursue a career in medicine focused on improving patient outcomes and reducing barriers to care.

Kun YanKun Yan is a rising senior studying Biology at Boston University with interests in translational medicine, patient-centered care, and rare disease advocacy. Through her clinical volunteering experiences and nephrology research at Boston Medical Center, she has developed a strong passion for bridging scientific research with compassionate healthcare. Outside of academics, Kun enjoys writing, swimming, fitness, and community outreach. She is excited to support the Lafora community by contributing to patient advocacy, educational initiatives, and ongoing efforts to improve treatments and advance research toward a cure.

Sonia WooSonia Woo is a rising sophomore studying Public Health and the Writing Seminars at Johns Hopkins University. She is passionate about rare disease advocacy, patient and family education, and health equity. Sonia is working on supporting the clinical network.

Soomin KimSoomin Kim is a rising junior at Johns Hopkins University studying Molecular and Cellular Biology and Psychology. She is passionate about the intersection of science and public health, and hopes to contribute through research and rare disease advocacy for underserved communities. Soomin aspires to learn more about bridging systemic gaps in healthcare access and accelerating treatments for rare disease patients through research.

Communications Interns

Danika Smidt​​Danika Smidt is a rising senior at the University of Colorado Boulder pursuing a BS in Molecular, Cellular, and Developmental Biology with minors in Biochemistry, Public Health, and Sociology. Outside of class, she is an active member of the Golden Buffalo Marching Band, serves as the VP of Finance for the Women’s Network, and is an ambassador for Morgan’s Message. Passionate about raising awareness on Lafora disease through social media, she is excited to start a new chapter and be a part of Chelsea’s Hope.

Deveny Gilmore​​Deveny Gilmore is a third-year genetics major at the University of Georgia on a pre-genetic counselor track. She is passionate about helping families find answers and understand their medical diagnoses. Deveny is creating infographics and resources for caregiver support, assisting with the recently launched Courage in Care program.

Jeanine AbedelalJeanine Abedelal is majoring in Communication Sciences and Disorders on a pre–Speech-Language Pathology and healthcare track at Northwestern University. She has a strong interest in pediatric care, neurodivergence, and rare disease advocacy. Jeanine was awarded a School of Communication Internship Grant through Northwestern University to support her work this summer. She is excited about the opportunity to contribute to Chelsea’s Hope and work toward advancing research and advocacy for Lafora disease.

Josie MilnerJosie Milner is majoring in Public Health with a minor in Business Administration at the University of Washington in Seattle. She is passionate about health education, community outreach, and creating accessible resources that help improve public health awareness.

 

Qianna Dudsic​​Qianna Dudsic studies molecular biology at the University of Washington. In her spare time, she enjoys reading, hiking, and listening to music. She is dedicated to making a meaningful impact in the Lafora community by bringing awareness to Lafora disease and raising support for the development of new treatments and a potential cure. She is excited to join Chelsea’s Hope and contribute to its mission.

Fundraising Support Interns

Isabella Connolly​​Isabella Connolly is a rising senior at the University of Maryland, where she is pursuing a Bachelor of Science in Global Health. In her free time, Isabella enjoys reading and spending time at the beach. Her passion for public health has inspired her interest in learning more about rare diseases and advocacy efforts. Through her role at Chelsea’s Hope, she hopes to contribute to the Lafora community by supporting fundraising initiatives and raising awareness about the disease.

Sereen Musleh​​Sereen Musleh is studying health science as a Pre-PA student based in Chicago, Illinois. She has a strong interest in neurology and previously worked as a pharmacy technician. Sereen recently earned her phlebotomy certification and is passionate about patient care as well as healthcare education. In her free time, Sereen enjoys baking and spending time outdoors.

Research Support Interns

Adaku IwudikeAdaku Iwudike is a Banneker Key Scholar studying Bioengineering at the University of Maryland, College Park. Adaku is passionate about advancing research for rare and chronic illnesses because she believes everyone deserves clarity about their health. Through this work, Adaku hopes to contribute to a future where technology advances our ability to understand disease earlier, provide clearer answers, and improve the lives of patients and families.

Anson ChauAnson Chau is a rising junior at UC Berkeley studying Integrative Biology and Public Health with a deep interest in chronic illnesses and education. He is excited to work with Chelsea’s Hope this summer to advocate for individuals and families affected by Lafora disease. Through this internship, Anson hopes to gain more hands-on research skills by contributing to the team and supporting our research roadmap project.

 

Elizabeth WildingElizabeth Wilding recently earned her Master of Public Health from the University of Virginia, where she focused on epidemiology, health data analysis, and public health research. Through her internship with Chelsea’s Hope, she looks forward to supporting the Lafora Research Network by contributing to research coordination, data analysis, and efforts to advance understanding of Lafora disease and improve outcomes for affected individuals and families.

 

Sara Ghoddoussi

​Sara Ghoddoussi graduated with her Bachelor of Science in Neuroscience from Wayne State University, with dual minors in Economics and Public Health. In the fall, she will begin pursuing a Master of Public Health in Health Behavior and Health Equity, along with a certificate in Public Health Genetics, at the University of Michigan. Sara is passionate about genetics, rare disease advocacy, community engagement, and improving access to health education.

Interns United for our Mission

Our summer team members are committed to improving the lives of those affected by Lafora disease and helping accelerate the development of treatments. Please join us in welcoming everyone as they assist with projects this summer, and don’t hesitate to contact us if you have any questions.

 

Updates for the Lafora Therapy Pipeline: Requesting information from our Research Community

At our 2025 Lafora Symposium, several of the Lafora patient organizations decided to work together to better support therapy development for Lafora disease.

To help us prioritize therapies to support, we are requesting periodic updates on novel and repurposed therapies in development for Lafora. If you are a clinician or researcher working on a Lafora Therapy, please complete this form so that we can educate families about your research and determine the best way to support the development of your therapy.

Submissions will be reviewed by A.I.L.A., Cel-Luz Association, Chelsea’s Hope, France Lafora,  and TempoZero.

 

Telethon’s Statement on the ION283 Clinical Trial Pathway for Lafora

Fondazione Telethon Logo

Fondazione Telethon has kindly provided Chelsea’s Hope and the other advocacy organizations with a statement for the Lafora patient community. At their request, we are sharing the communication below:

Dear Members of the International Lafora Patient Community,

Fondazione Telethon remains open to contributing to the development of ION283 and to collaborating with partners in Europe and in the United States, provided that the highest ethical and scientific standards are upheld and that any decision is taken exclusively in the best interest of patients.

Fondazione Telethon acknowledges the complexity of the ION283 case, also from the perspective of Ionis, which currently holds the license for the compound.

The essential authorizations required to set up a clinical study in Italy fall within Ionis’ decision-making space. Therefore, at this stage, Fondazione Telethon cannot serve as the reference point or source of information regarding a possible future development path for ION283. The decision concerning the continuation, redesign, or activation of a clinical program is not under our direct control. Should concrete and reliable updates become available, we will share them promptly.

We are aware that several research groups, in different Countries, are actively conducting studies on Lafora disease: this reflects the commitment of the international scientific community to advancing knowledge and identifying potential therapeutic strategies.

While dealing with the hard work to ensure progresses in identifying therapeutic solutions, we respectfully invite families, associations, and researchers to bear in mind that the scientific pathway required to transform science in therapies does not allow for shortcuts. The timelines necessary to ensure safety, efficacy and compliance with regulatory standards cannot be compressed beyond what scientific rigor and ethical standards allow.

We are aware that this message may sound demanding. However, clarity is necessary to preserve families who are already facing extraordinary challenges and a sense of unpostponable urgency every day.

Our commitment remains firm: to pursue research with responsibility, scientific soundness, transparency, and deep respect for patients and their loved ones.

As a reminder, please email your questions or concerns to ion283@chelseashope.org.